Tian An MedicareCOLRF 45 EBIT per Share is $0.00 as of Dec. 2025. GuruFocus rates COLRF with a GF Score™ of 45/100 and a GF Value™ of $0.07. The stock has 4 warning signs investors should review. Among 529 Healthcare Providers & Services companies, Tian An Medicare ranks worse than 189035.73% on this metric.
Tian An Medicare's EBIT per Share for the
six
months ended in Dec. 2025 was $-0.00.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $0.00.
During the past 12 months, the average EBIT per Share Growth Rate of Tian An Medicare was -47.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Tian An Medicare's EBIT per Share or its related term are showing as below:
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Tian An Medicare was 162.00% per year. The lowest was -406.60% per year. And the median was 7.80% per year.
COLRF's 3-Year EBIT Growth Rate is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 11.8 * Ranked among companies with meaningful 3-Year EBIT Growth Rate only.
Tian An Medicare (OTCPK:COLRF) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Tian An Medicare EBIT per Share Related Terms
Tian An Medicare EBIT per Share Historical Data
* Premium members only.
The historical data trend for Tian An Medicare's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tian An Medicare (COLRF) has a EBIT per Share of $0.00 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Tian An Medicare and its competitors. According to the industry distribution chart, Tian An Medicare ranks #999999 out of 529 companies in the Healthcare Providers & Services industry.
Is Tian An Medicare's EBIT per Share too high?
Tian An Medicare's current EBIT per Share is $0.00. Based on the distribution chart, Tian An Medicare ranks #999999 out of 529 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Tian An Medicare has a GF Score™ of 45/100, reflecting its overall financial health beyond just this single metric.
How does Tian An Medicare's EBIT per Share compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Tian An Medicare ranks #999999 out of 529 companies for EBIT per Share. This places Tian An Medicare in the lower half of its industry. The industry median EBIT per Share is 11.80. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 11.80, based on 529 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Tian An Medicare and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 11.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tian An Medicare's current EBIT per Share is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tian An Medicare stock overvalued right now?
Tian An Medicare (COLRF) has a current EBIT per Share of $0.00. The stock's GF Value™ is $0.07, compared to a current price of $0.08 — trading 14.3% above its estimated fair value. The current EBIT per Share is $0.00. Tian An Medicare's overall GF Score™ is 45/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Tian An Medicare (COLRF), the current EBIT per Share is $0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tian An Medicare (COLRF) Overvalued in 2026?
Based on GuruFocus' analysis, Tian An Medicare stock appears to be overvalued.
The current stock price of $0.08 is trading 14.3% above its estimated GF Value™ of $0.07.
Key valuation signals for COLRF:
EBIT per Share: $0.00
GF Value™: $0.07 vs. price of $0.08 (14.3% above fair value)
No single metric tells the full story. See the COLRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tian An Medicare Ltd is an investment holding company and operator of integrated healthcare and eldercare services. Its main focus is on the investment, management and operations of healthcare and eldercare businesses, and the related property investment and development, and comprehensive spectrum of healthcare and eldercare services to customers in the People's Republic of China (PRC) and Asia Pacific. The Group is also involved in businesses of securities trading and investment, and provision of financial services. Its segments includes: Healthcare; Eldercare; and Property Development, of which it derives maximum revenue from Healthcare segment.
45GF Score
Get the complete analysis for COLRF
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
COLRF has been successfully added to your 
